1. Home
  2. STTK vs ASG Comparison

STTK vs ASG Comparison

Compare STTK & ASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$6.00

Market Cap

275.9M

Sector

Health Care

ML Signal

HOLD

ASG

Liberty All-Star Growth Fund Inc.

HOLD

Current Price

$4.92

Market Cap

323.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
STTK
ASG
Founded
2016
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
275.9M
323.4M
IPO Year
2020
1995

Fundamental Metrics

Financial Performance
Metric
STTK
ASG
Price
$6.00
$4.92
Analyst Decision
Buy
Analyst Count
7
0
Target Price
$7.60
N/A
AVG Volume (30 Days)
589.2K
268.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
53.02
N/A
EPS
N/A
N/A
Revenue
$1,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.69
$4.01
52 Week High
$6.27
$5.69

Technical Indicators

Market Signals
Indicator
STTK
ASG
Relative Strength Index (RSI) 71.72 39.68
Support Level $1.85 N/A
Resistance Level N/A $5.57
Average True Range (ATR) 0.42 0.08
MACD 0.09 -0.01
Stochastic Oscillator 89.41 29.73

Price Performance

Historical Comparison
STTK
ASG

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

About ASG Liberty All-Star Growth Fund Inc.

Liberty All Star Growth Fund Inc is the United States based diversified, closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investment in a diversified portfolio of equity securities. The company portfolio of investments consists of different industries such as consumer discretionary, consumer staples, healthcare, industrial, information technology and others.

Share on Social Networks: